Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity
after allogeneic stem cell transplantation. Though perfect response rates are not achieved …

Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

BACKGROUND Extracorporeal photopheresis (ECP) has demonstrated efficacy as second‐
line treatment for steroid‐refractory (SR) acute graft‐versus‐host disease (aGVHD). The aim …

Background The clinical use of extracorporeal photopheresis (ECP) is based on its ability to
induce cell‐mediated immune tolerance towards foreign and self‐antigens. Up‐to‐date, no …

Extracorporeal photochemotherapy (ECP) has been progressively introduced into the
treatment of both acute and chronic graft‐versus‐host disease (cGvHD) over the last …

Extracorporeal photochemotherapy, or photopheresis is a low-risk therapeutical
intervention, which has been introduced in a variety of hematological malignancies …

xtracorporeal phototherapy (ECP) is a cellular therapy that has demonstrated efficacy in a
number of autoimmune and T-cell-mediated processes, including scleroderma and …

Background Chronic graft‐versus‐host disease (cGVHD) is a major complication of
allogeneic bone marrow transplantation. Extracorporeal photopheresis (ECP) has recently …

Hematopoietic stem cell donation is a method used to treat both blood-related and non-
blood-related malignancies. Graft-versus-host disease is a potentially life-threatening …

Graft-versus-host disease (GvHD) is a serious complication of allogeneic hematopoietic cell
transplantation causing significant morbidity and mortality. Corticosteroids are the …